Millen, Gerard C. http://orcid.org/0000-0003-1446-3228
Lawford, Alice
Duncan, Catriona
Jenkinson, Helen
Veal, Gareth J.
Barnett, Shelby
Article History
Received: 12 February 2024
Revised: 12 May 2024
Accepted: 16 May 2024
First Online: 13 June 2024
Competing interests
: The authors declare no competing interests.
: For patients registered on the clinical trial (ISRCTN 10139334) the study was approved by the Newcastle & North Tyneside Research Ethics Committee. All patients provided written informed consent prior to study enrolment in accordance with the Declaration of Helsinki, the International Conference on Harmonisation for Good Clinical Practice and applicable local regulations. All other patients had standard clinical consent taken for chemotherapy and TDM.